AMELUZ gel 78 mg/g tb 2 g

7680656930017 CH-65693 L01XD04 07.16.4.

Reimbursement limitations:

AMELUZ2

Pour le traitement de la kératose actinique légère à modérée et des champs de cancérisation.

AMELUZ gel 78 mg/g tb 2 g
AMELUZ gel 78 mg/g tb 2 g
AMELUZ gel 78 mg/g tb 2 g
1 / 3
google

Details

Product number
6569301
CPT
-
Packaging group
2
Unit
g
Composition
acidum aminolaevulinicum 78 mg ut aminolaevulinatis hydrochloridum, xanthani gummi, phosphatidylcholinum ex soja hydrogenatum, polysorbatum 80, triglycerida media, alcohol isopropylicus, dinatrii phosphas dihydricus, natrii dihydrogenophosphas dihydricus, propylenglycolum 10 mg, aqua purificata, natrii benzoas 2.36 mg, ad gelatum pro 1 g.

Articles (1)

Ameluz 78 mg/g, Gel
Gel
2
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
17/05/2022
Professional SmPC
Français
17/05/2022
Professional SmPC
Italien
17/05/2022

Detailed composition

Substance Quantity Type Category
(N/A)
78.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
2.36 MG Substance HBESI
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 226.50
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/04/2016

Authorization holder

Louis Widmer AG

8952 Schlieren

Authorization information

Swissmedic authorization number
65693
Drug name
Ameluz, Gel
Galenic form
GELK
ATC Code
L01XD04
Authorization status
Z
Dispensation category
B
First authorization
26/11/2015
Authorization expiration date
31/12/9999
IT number
07.16.4.
Domain
Human medicine
Field of application
Aktinische Keratosen, superfizielles und/oder noduläres Basaliom

Packaging details

Description (FR)
AMELUZ gel 78 mg/g tb 2 g
Description (DE)
AMELUZ Gel 78 mg/g Tb 2 g
Market launch
26/11/2015
Narcotic (BTM)
No